ORIUCHI NOBORU

J-GLOBAL         Last updated: May 31, 2016 at 11:47
 
Avatar
Name
ORIUCHI NOBORU

Research Interests

 
 

Research Areas

 
 

Academic & Professional Experience

 
 
   
 
Associate Professor, Gunma University Graduate School of Medicine, Biosystem Medicine Oncology
 

Education

 
 
 - 
1991
Graduate School, Division of Medical Sciences, Gunma University
 
 
 - 
1985
Faculty of Medicine, Gunma University
 

Misc

 
Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
KATO Hiroyuki / MIYAZAKI T / NAKAJIMA M / TAKITA J / KIMURA H / FARIED A / SOHADA M / FUKAI Y / MASUDA N / FUKUCHI M / MANDA R / OJIMA H / TSUKADA K / KUWANO H / ORIUCHI N / ENOD KEIGO
Anticancer Res   25 4439-4444   2005
Usefulness of dual-head coincidence gamma camera with thick NaI crystals for nuclear oncology: Comparison with dedicated PET camera and conventional gamma camera with thin NaI crystals.
Inoue T. / ENDO KEIGO / ORIUCHI NOBORU / Koyama K. / Ichikawa A. / Tomiyoshi K. / SATO NORIKO / Matsubara K. / Suzuki H. / AOKI JUN
Annals of Nuclear Medicine   15:141-148    2001
Zhang H. / Inoue T. / Alyafei S. / Tian M. / ORIUCHI NOBORU / ENDO KEIGO
Nuclear Medicine Communications   22:305-314    2001
A basic study on lesion detectability for hot spot imaging of positron emitters with dedicated PET and positron coincidence gamma camera.
Zhang H. / Inoue T. / Tian M. / Alyafei S. / ORIUCHI NOBORU / Khan N. / Li S. / ENDO KEIGO
Annals of Nuclear Medicine   15: 301-306    2001
Detection of malignant tumors: Whole-body PET with fluorine 18 a-methyl tyrosine versus FDG-Preliminary study.
Inoue T. / AOKI JUN / ENDO KEIGO / Koyama K. / ORIUCHI NOBORU / Alyafei, S. / Yuan, Z. / Suzuki H. / Takeuchi K. / Tomaru Y. / Tomiyoshi K.
Radiology   220:54-62    2001

Books etc

 
Artifacts in FDG-PET. Clinical PET Principles and Applications (Kim EE, Lee MC, Inoue T, Wong WH, eds)
Springer   2004   
Targeted Molecular Imaging in Oncology
Springer-Verlag, New York   2000   
Present and future of nuclear nephro-urology. In: Nishimura T, Strauss HW, and Fukuchi M, eds. The Scintillating Future of Nuclear Medicine-Kobe
Elsevier   2000   
Radioimmunodetection of Colorectal Cancer Using 99mTc-Labeled Anti-CEA Antibody - Evaluation of Tumor-to-Normal Tissue Ratio on SPECT Images -. In: Matsuzawa T, ed.
1993   
Malignancy of glioma estimated by PET-18F-FDG, PET-11C-methionine, and SPECT-201Thallium. In: Tabuchi K, ed. Biological aspect of brain tumors.
Springer-Verlag, Tokyo   1991   

Conference Activities & Talks

 
Noninvasive determination of regional myocardial perfusion and perfusion reverse with first-pass MR imaging
Progress in Radiology 2004   2004   
Clinical study using L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor with analysis on cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1).
The Second International Symposium on Biomedical Research Using Accelerator Technology   2005   
Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody, NuB2, for cancer therapy.
52th Annual Meeting of the Society of Nuclear Medicine   2005   
A preliminary of the usefulness of L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) PET in the evaluation of malignancy of maxillofacial tumor; Comparative study with 18F-FDG PET and immunohistochemical analysis of cellular proliferation (Ki-67) and amino-a・・・
EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine   2005   
A preliminary of the usefulness of L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) PET in the evaluation of malignancy of maxillofacial tumor; Comparative study with 18F-FDG PET and immunohistochemical analysis of cellular proliferation (Ki-67) and am...
Preclinical Evaluation of Radiolabeled Anti-CD20 Monoclonal Antibody, NuB2, for Cancer Therapy.
EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine   2005